Bai Xue, Liu Zhejun, Tang Tian, Yu Shujun, Liu Dan, Liu Guimin, Fan Xiaolei, Tang Yibo, Liu Zhenquan
Beijing Key Laboratory of TCM Basic Research on Prevention and Treatment of Major Disease, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol. 2022 Aug 11;13:794448. doi: 10.3389/fphar.2022.794448. eCollection 2022.
Male infertility is a major and growing health problem with an estimated global prevalence of 4.2%. The current therapy is limited by the unknown etiology of MI, emphasizing the critical requirement forward to a more efficient method or medication. Through thousands of years, Traditional Chinese Medicine (TCM) has been shown to be effective in treating MI effectively. However, the components, mechanisms and functions of TCM prescriptions on MI are still obscure, severely limiting its clinical application. In order to discover the molecular mechanism of TCM against MI, our study presents a comprehensive approach integrated data mining, network pharmacology, molecular docking, UHPLC-Q-Orbitrap HRMS, and experimental validation. Here, we begin to acquire 289 clinical TCM prescriptions for MI from a TCM hospital's outpatient department. Then, Core Chinese Materia Medica (CCMM) was then retrieved from the TCM Inheritance Support System (TCMISS), which was utilized to discover the underlying rules and connections in clinical prescriptions. After that, 98 CCMM components and 816 MI targets were obtained from ten distinct databases. Additionally, the network pharmacology methods, including network construction, GO and KEGG pathway enrichment, PPI analysis, were utilized to reveal that kaempferol, quercetin, isorhamnetin, and beta-sitosterol are the core components of CCMM in treating MI. The mechanisms and functions of CCMM against MI are hormone regulation, anti-apoptosis, anti-oxidant stress, and anti-inflammatory. Furthermore, the strong connections between four core components and six key targets were verified using a molecular docking method. Following that, the core components of the CCMM extract were identified using UHPLC-Q-Orbitrap HRMS analysis. Finally, experiments demonstrated that CCMM and four core components could improve the density, motility, viability of sperm, lecithin corpuscle density, decrease the rate of sperm malformation and testis tissue damage, and regulate the protein expressions of AKT1, MAPK3/1, EGFR, and TNF-α in a mouse model of MI. UHPLC-Q-Orbitrap HRMS analysis and experiments further validated the results of data mining, network pharmacology, and molecular docking. Our study could uncover the components, mechanisms, and functions of TCM prescriptions against MI and develop a new integrative approach to demonstrate TCM's multi-component, multi-target, and multi-pathway approach to disease treatment.
男性不育是一个重大且日益严重的健康问题,全球估计患病率为4.2%。目前的治疗方法受到男性不育病因不明的限制,这凸显了对更有效方法或药物的迫切需求。数千年来,传统中医(TCM)已被证明在有效治疗男性不育方面具有疗效。然而,中医方剂治疗男性不育的成分、机制和功能仍不明确,严重限制了其临床应用。为了发现中医治疗男性不育的分子机制,我们的研究提出了一种综合方法,整合了数据挖掘、网络药理学、分子对接、超高效液相色谱-四极杆-轨道阱高分辨质谱(UHPLC-Q-Orbitrap HRMS)和实验验证。在此,我们首先从一家中医医院门诊部获取了289个治疗男性不育的临床中医方剂。然后,从中医传承辅助系统(TCMISS)中检索核心中药(CCMM),用于发现临床方剂中的潜在规律和联系。之后,从十个不同的数据库中获得了98种CCMM成分和816个男性不育靶点。此外,利用网络药理学方法,包括网络构建、基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集、蛋白质-蛋白质相互作用(PPI)分析,揭示了山奈酚、槲皮素、异鼠李素和β-谷甾醇是CCMM治疗男性不育的核心成分。CCMM治疗男性不育的机制和功能包括激素调节、抗凋亡、抗氧化应激和抗炎。此外,使用分子对接方法验证了四种核心成分与六个关键靶点之间的紧密联系。随后,通过UHPLC-Q-Orbitrap HRMS分析鉴定了CCMM提取物的核心成分。最后,实验表明,在男性不育小鼠模型中,CCMM和四种核心成分可以提高精子密度、活力、存活率、卵磷脂小体密度,降低精子畸形率和睾丸组织损伤,并调节AKT1、MAPK3/1、表皮生长因子受体(EGFR)和肿瘤坏死因子-α(TNF-α)的蛋白表达。UHPLC-Q-Orbitrap HRMS分析和实验进一步验证了数据挖掘、网络药理学和分子对接的结果。我们的研究可以揭示中医方剂治疗男性不育的成分、机制和功能,并开发一种新的综合方法来证明中医治疗疾病的多成分、多靶点和多途径方法。